Patent · US Active

Truncated L1 protein of Human Papillomavirus type 16

US9428555B2 · kind B2 · utility

0Cited by

13References

17Claims

0Family size

Assignees

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. · CN
XIAMEN UNIVERSITY · CN

Inventors

Ying Gu · Fujian, CN
Shaowei Li · Potomac, US
Minxi Wei · Xiamen, CN
Yangling Xian · Fujian, CN
Wenxin Luo · Xiamen, CN
Ningshao Xia · Fujian, CN

Key dates

Filing date	Apr 29, 2008
Grant date	Aug 30, 2016
Priority date	—
Expiry date	Mar 28, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2710/20034
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a truncated L1 protein of the Human Papillomavirus Type 16, a virus-like particle consisting of the protein, a vaccine comprising said virus-like particle, and the use of the vaccine in the prevention of cervical cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.